Skip to content

Therapeutic Education in Very Young Children With Diabetes Mellitus

Therapeutic Education in Very Young Children With Diabetes Mellitus. Evaluation of the Impact of a Specific Tool for Parents on Glycemic Control and Prevention of Acute Events (Hypoglycemia and Ketosis)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01354288
Acronym
DIAB-EDUC
Enrollment
24
Registered
2011-05-16
Start date
2011-12-07
Completion date
2014-12-01
Last updated
2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 1 Diabetes

Keywords

Diabetes, Children, Disease management, Ketosis, Hypoglycemia, Parents, Education

Brief summary

DIAB-EDUC tests in a group of young diabetic patients (less than 6 years old) a specific educational tool in order to assess its impact on glycemic control, quality of life, knowledge about the disease and its daily management, over a period of 2 years. The investigators plan to include 300 type 1 diabetic children in 10 french hospitals.

Detailed description

General frame : 1 inclusion / randomization visit and delivery of the educational tool for patients of the "Therapeutic Education" arm, then follow-up visits every 6 months during 24 months. V0 - Inclusion / randomization visit - Verification of eligibility - Clinical examination and data report - Blood samples for lab tests (HbA1c assay)- Collection of signed consent form- DIAB-EDUC questionnaire (diabetes knowledge, treatment, quality of life, hypoglycaemia and emergency situations, parental stress)- Randomization - Education tool explanation and delivery by the physicians to parents randomized in " Experimental " arm M6 - Visit at 6 months- Clinical examination and data report- Blood samples for lab tests (HbA1c assay) M12 - Visit at 12 months- Clinical examination and data report- Blood samples for lab tests (HbA1c assay)- DIAB-EDUC questionnaire M18 - Visit at 18 months- Clinical examination and data report- Blood samples for lab tests (HbA1c assay) M24 - Visit at 24 months- Clinical examination and data report- Blood samples for lab tests (HbA1c assay)- DIAB-EDUC questionnaire

Interventions

Specific educational tool in order to assess its impact on glycemic control, quality of life, knowledge about the disease and its daily management

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
12 Months to 6 Years
Healthy volunteers
No

Inclusion criteria

* Children with type 1 diabetes aged 1 to 6 years * Disease evolution more than 1 year * HbA1c \> 8% or at least one acute accident (hypoglycemia or ketosis) during the last year * Specific information given to parents from the physicians and consent form signed by the parents * Physical examination of the children at enrolment- patient affiliated with or receiving health insurance

Exclusion criteria

* Non-insulin dependent diabetes * Monogenic diabetes (MODY) * Severe co-morbidities- cognitive disabilities or psychosocial disadvantage compromising the therapeutic education * Children whose parents have a disorder of comprehension or expression of the French Language * Patients included in another interventional trial

Design outcomes

Primary

MeasureTime frame
HbA1c 12 months after therapeutic education12 months

Secondary

MeasureTime frame
HbA1C 24 months after therapeutic education24 months
Acute events number (hypoglycemia and ketosis) over a 12 and 24 months period12 and 24 months
Evolution of the parental knowledge about the disease 12 and 24 months after therapeutic education (evaluated by questionnaire)12 and 24 months
Evolution of the parental stress 12 and 24 months after therapeutic education (evaluated by questionnaire)12 and 24 months
Evolution of the parental and child quality of life 12 and 24 months after therapeutic education (evaluated by questionnaire)12 and 24 months

Countries

France

Contacts

PRINCIPAL_INVESTIGATORPierre BOUGNERES, MD, PhD

Bicêtre Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026